Status:
COMPLETED
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
Lead Sponsor:
AbbVie (prior sponsor, Abbott)
Collaborating Sponsors:
Quintiles, Inc.
Conditions:
Advanced Parkinson's Disease
Eligibility:
All Genders
30+ years
Phase:
PHASE3
Brief Summary
The primary objective of this study was to demonstrate the superiority of levodopa - carbidopa intestinal gel over treatment with optimized oral levodopa/carbidopa during 12 weeks.
Detailed Description
Study S187.3.001 (NCT00357994) and Study S187.3.002 (NCT00660387) were 2 identically designed, Phase 3, 12-week, randomized, double-blind, double-dummy, parallel-group, multicenter studies recruiting ...
Eligibility Criteria
Inclusion
- Idiopathic Parkinson's disease (PD) according to United Kingdom Parkinson's Disease Society (UKPDS) Brain Bank Criteria
- Levodopa-responsive participants who demonstrate some identifiable 'on response,' established by Investigator observation
- Demonstrate severe motor fluctuations in spite of individually optimized treatment and where therapy options are indicated
Exclusion
- Diagnosis is unclear or a suspicion of other parkinsonian syndromes exists such as secondary parkinsonism
- Undergone surgery for the treatment of PD
- Contraindications to levodopa
- Subjects with any neurological deficit that may interfere with the study assessments
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00357994
Start Date
January 1 2009
End Date
October 1 2011
Last Update
January 16 2015
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Reference ID/Investigator# 45719
Los Angeles, California, United States, 90033
2
Site Reference ID/Investigator# 45718
Englewood, Colorado, United States, 80113
3
Site Reference ID/Investigator# 45722
Washington D.C., District of Columbia, United States, 20007
4
Site Reference ID/Investigator# 45721
Bradenton, Florida, United States, 34205